- Technical advance
- Open Access
- Open Peer Review
Developing a standardized healthcare cost data warehouse
BMC Health Services Research volume 17, Article number: 396 (2017)
Research addressing value in healthcare requires a measure of cost. While there are many sources and types of cost data, each has strengths and weaknesses. Many researchers appear to create study-specific cost datasets, but the explanations of their costing methodologies are not always clear, causing their results to be difficult to interpret. Our solution, described in this paper, was to use widely accepted costing methodologies to create a service-level, standardized healthcare cost data warehouse from an institutional perspective that includes all professional and hospital-billed services for our patients.
The warehouse is based on a National Institutes of Research–funded research infrastructure containing the linked health records and medical care administrative data of two healthcare providers and their affiliated hospitals. Since all patients are identified in the data warehouse, their costs can be linked to other systems and databases, such as electronic health records, tumor registries, and disease or treatment registries.
We describe the two institutions’ administrative source data; the reference files, which include Medicare fee schedules and cost reports; the process of creating standardized costs; and the warehouse structure. The costing algorithm can create inflation-adjusted standardized costs at the service line level for defined study cohorts on request.
The resulting standardized costs contained in the data warehouse can be used to create detailed, bottom-up analyses of professional and facility costs of procedures, medical conditions, and patient care cycles without revealing business-sensitive information.
After its creation, a standardized cost data warehouse is relatively easy to maintain and can be expanded to include data from other providers. Individual investigators who may not have sufficient knowledge about administrative data do not have to try to create their own standardized costs on a project-by-project basis because our data warehouse generates standardized costs for defined cohorts upon request.
A challenge for researchers addressing value-based healthcare is how to measure cost for public dissemination of research results . There are many types of costs; the most commonly used are direct healthcare costs (e.g. professional services, supplies, medical facilities).
Direct healthcare costs are obtainable from many different sources. Information about charges may be available publicly, but charges do not accurately reflect either provider or payer cost because of markups and discounts . Actual reimbursement is a useful cost measure, but many providers do not have data systems that link payments to specific services, and those who do also need to be aware of antitrust or payer contract issues when the information is disclosed [3, 4]. Reimbursement in the form of claims data from payers has limitations as well. Medicare and Medicaid claims data cover only segments of the population. In addition, Medicare and Medicaid use a prospective payment system for facility costs that apply fixed payments to groups of services. For example, the effect of length of stay on cost cannot be measured. Commercial insurance claims, including actual reimbursement, are usually de-identified with respect to patients and providers. In addition, different contract terms produce different unit costs for providers of the same service .
Internal costs are the most useful measure for providers to evaluate cost drivers and increased efficiencies, but not all providers have complete cost-accounting systems . Furthermore, many providers consider these internal costs to be business sensitive and do not want them shared publicly. Although proportions and percent changes in actual costs might be published, results can be difficult to interpret without a dollar frame of reference. Finally, many authors appear to create their own study- specific cost datasets based on a mixture of these cost types, although this process can be expensive . The explanations of their costing methodologies are not always clear, so their findings may be difficult to interpret .
This paper describes our solution, which was to create a standardized cost data warehouse that uses accepted methodology  to assign a relative dollar value of resources to every billed professional and hospital service provided to every patient (microcosting). We demonstrate how investigators can create a cost data warehouse that can be used to support detailed, bottom-up analyses of professional and facility costs of procedures, medical conditions, and patient care cycles without revealing business-sensitive information.
We have two cost data warehouses that share the same reference file and programming code infrastructure: one for the National Institutes of Health–funded Rochester Epidemiology Project (REP) and one for Mayo Clinic in Rochester. Both were formerly known as the Olmsted County Healthcare Expenditure and Utilization Database. The REP warehouse is affiliated with the larger REP [9, 10], which is a research infrastructure containing the linked health records and medical care administrative data of virtually all persons residing in our county. An electronic data-sharing agreement was signed by the leaders of Mayo Clinic campus in Rochester, Minnesota, and the Olmsted Medical Center (OMC) in 1995 for the purpose of sharing and archiving patient-level administrative data on healthcare utilization and the associated direct medical costs of care.
The REP warehouse uses billing data from Mayo Clinic in Rochester and the OMC and their affiliated hospitals for Olmsted County residents; by comparison, the Mayo Clinic warehouse currently uses only billing data from Mayo Clinic in Rochester for all patients regardless of where they live. The primary focus of this paper is the REP cost data warehouse.
Data are extracted from the institutions’ financial decision support systems (DSSs), which combine data from many sources to support practice analytics. The data include billing services, charges, diagnoses, patient demographic characteristics, payer information, individual provider information, and, for one institution, the internal costs. The advantage of using DSSs is that all data are already linked within the two institutions at the patient level, reducing the potential for errors when combining various patient, provider, charge, diagnosis, and billing files for professional and hospital services. The REP infrastructure performs the higher level linkage of patients across institutions . Mayo Clinic DSS data are stored in an enterprise data warehouse; OMC DSS data are stored in the epidemiology program’s database (Sybase; SAP SE). In order to protect business-sensitive information, no internal costs or insurance information from the two institutions are included in the data warehouse and access to the OMC source data is limited to staff who are affiliated with REP. Investigators are prohibited from comparing the two institutions.
Changes in one institution’s DSS and adoption of a DSS by the other institution allowed us the opportunity to revisit the costing process and structure that had been in effect for OCHEUD for many years. We updated the programming code to refine the costing process and eliminate standardized cost data storage. We also distinguished between the REP and MCR populations by creating two warehouse names. The new warehouse requires no new storage space, is easier to maintain and to expand to other providers, and produces standardized costs for a requested cohort much faster. The relationship between the REP cost data warehouse, source files, and REP with the data fields used by the warehouse is shown in Fig. 1.
We have found that at a minimum, we need the following DSS data fields for each service: patient identifier, date of service, internal charge master code, the Healthcare Common Procedure Coding System (HCPCS) or Current Procedural Terminology Fourth Edition (CPT-4) code, all CPT-4 code modifiers, place of service (hospital vs clinic), quantity, charge, uniform billing (UB) revenue code, and a final billed indicator that refers to the final claim submission.
Our costing algorithm is a hybrid of two methods: one for professional services billed to all payers on the Centers for Medicare and Medicaid Services (CMS) 1500 form and one for hospital services billed to all payers on the UB04 or CMS 1450 form. Details about how we handled special circumstances as well as sample SAS code are provided in Additional files 1 and 2, Additional files 3 and 4: Tables S1 and S2.
Professional services identified with either HCPCS or CPT-4 codes are assigned standardized costs by using national reimbursement amounts from the appropriate Medicare physician, clinical laboratory, Medicare part B drug average sales price, and durable medical equipment, prosthetics, orthotics, and supplies fee schedules. Services without an assigned Medicare fee, most of which are carrier-priced, are assigned a gap code fee from The Complete RBRVS Annual Data File (Optum360, Inc) . These Medicare and Optum360 fees are based on relative value units (RVUs) that estimate relative resource utilization; although these fees represent third-party payer costs, they estimate relative provider costs as well. The sources of these reference files are listed in Table 1. Assigned costs are multiplied by quantity and then adjusted by appropriate modifier percentages (Table 2). A zero charge results in a zero cost. If a service has a negative charge and quantity reflecting a billing correction, it is assigned a negative cost.
The Physician Fee Schedule (PFS) includes three types of RVUs—for work, practice expense, and malpractice expense. The RVUs are summed and then multiplied by a conversion factor. The PFS and gap schedules contain different practice expense RVUs for many services, depending on whether the service was performed in a facility (e.g., hospital) or a nonfacility (or clinic) setting, because the allowable practice expense for the physician is lower where the facility can bill separately. Therefore, the place of service must be considered when determining the appropriate fee. PFS and gap schedules also include separate fees for some services among three different modifiers: 26 (or professional component), TC (technical component), and 53 (or discontinued procedure), so services with one of these modifiers in any of the four possible CPT-4 modifier fields must be matched to the fee schedules on both CPT-4 and modifier.
Anesthesia costing is more complex. Professional anesthesia reimbursement is based on time spent for a procedure, so there are no set fees for the CPT-4 codes. Three types of units—base, time, and physical status—are summed and then multiplied by a conversion factor. The base units are determined by the CPT-4 code that indicates the type of surgery and anesthesia. Time units are equal to the number of minutes divided by 15, then rounded to 0.1. Physical status units are determined by the American Society of Anesthesiologists physical status modifiers (ie, P1–P6) (Table 2), which represent a patient’s fitness before surgery. Finally, the resulting cost may be decreased by 50% when certain modifiers (listed in Table 2) indicate that more than one person performed the service, such as a physician who supervised an assistant or nurse anesthetist. The conversion factors are listed in the CMS file by locality; we use the national average value for each year. Alternatively, when billing conversion factors are available for the services in the DSS, charges can be divided by the billing conversion factors and multiplied by Medicare conversion factors to obtain the same result.
Any nonanesthesia professional services that do not map to a fee schedule are assigned an imputed cost by multiplying the charge by an average professional service cost to charge ratio (CCR). Figure 2 illustrates the decision process for all professional services.
Since Medicare reimbursement for hospital services is based on a prospective payment, it cannot be used to create standardized costs for individual inpatient and outpatient services, such as supplies or use of an operating room. Therefore, we use CCRs from the Medicare cost report to convert charges for individual services into standardized costs. The Research Data Assistance Center provides excellent instruction for how to obtain the CCRs, so we do not go into those details here . The challenge lies in what to do with the ratios.
Every hospital’s cost report contains hospital total costs and charges and a set of costs and charges aligned with various cost centers that can be used to calculate hospital level and cost center level CCRs. Although the Healthcare Cost and Utilization Project  provides hospital-level ratios for charge-to-cost conversion, we use cost center level CCRs to provide more accurate service level costs [2, 15]. There are two ways to map these CCRs to individual services: 1) match on the internal cost or revenue center that was used to assign the charges and costs to the cost report cost center and 2) use UB revenue codes, which are used by most researchers and the University HealthSystem Consortium . For such services as room and board, the result is the same. We opted to use revenue codes since internal cost or revenue center information was not available for one institution and it was difficult to maintain the mappings for the other institution.
We created a crosswalk of UB revenue codes to cost report cost centers for each institution. When we did not have a good match, we used the hospital average CCR. Table 3 contains a sample from one crosswalk. Medicare occasionally creates new cost centers that need to be considered during our annual updates (e.g., computed tomography and magnetic resonance imaging were split from Diagnostic Radiology in 2011). We found that some CCRs varied between the two hospitals of Mayo Clinic and varied over time mainly because of changes in cost report preparation. We addressed this variation by combining the costs and charges of these two Mayo hospitals and then using 3 consecutive years of costs and charges to create 3-year moving average ratios. We also use moving average ratios for the OMC hospital. Since cost report availability is delayed by about 1 year, we continue to use the preceding year’s ratios for the current year’s services until a new report is available.
The resulting assigned costs for all services are adjusted for inflation using the gross domestic product (GDP) Implicit Price Deflator [17, 18] to the final year of an investigator’s study period as the last step in the costing algorithm.
The warehouse consists of SAS software version 9.4 (SAS Institute Inc.) code and a set of reference files. All professional costing fee schedules are stacked into one file containing columns for CPT-4 and HCPCS codes (listed in a sole column), modifier, year, nonfacility fee, facility fee, and source fee schedule. They are arranged first by year, then code, and then modifier for every code. Since only the PFS and gap schedule have separate fees for some facility and nonfacility services, the same fee often appears in both columns. This one file is used for both institutions and currently contains over 246,000 lines for 2003 through 2015.
Three additional reference files are needed for costing professional services: modifiers with associated cost adjustment percentages, anesthesia conversion factors by year, and imputation rates by year and institution. Imputation rates are used to estimate a cost where a professional service cannot be mapped to a non-zero fee. An annual rate is created by running the costing algorithm against all of the data for a service year. We then calculate the ratio of the total assigned fees to the total charges for all services (excluding zero-charge services) to create an average standardized cost-to-charge imputation rate that can be multiplied by the imputed services’ charges.
The two institutions’ hospital costing reference files each contain the CCRs, year, and UB revenue codes arranged first by year and then by revenue code. The creation of the CCR files is a manual process because it requires judgment about which cost center costs and charges need to be combined to create ratios (eg, operating room, recovery room) and which ratios are mapped to the various UB revenue codes. The inflation file is organized first by the year in which the service occurred and then by the target year to which costs are to be inflated, with an inflation index consisting of the GDP of the target year divided by the GDP of the service year for every combination of years.
When we reach a new calendar year, we download the new year of CMS files, purchase the new Optum Gap Code schedule, download inflation factors from the Bureau of Labor Statistics, access the institutions’ cost reports to create new cost to charge ratios, and apply our SAS code to update the reference files. We apply the costing algorithm to assign uninflated and inflated costs and an indicator of the costing methodology (i.e., PFS, laboratory, DME (durable medical equipment), drug, gap, anesthesia, CCR, zero charge, or impute) to every service in the new time period and run quality control. Our quality control code identifies issues such as UB revenue codes in the data that need to be added to the CCR reference file. The quality control outputs a list of all CPT-4 codes that are imputed so we can determine whether a reference file adjustment is needed. Our quality control also looks at trends in charges and costs over time and checks the proportions of the various cost methods in the data. Finally, samples of data are manually validated to ensure accuracy.
Expansion of the cost data warehouse to a new provider requires primarily the creation of a new set of provider-specific cost to charge ratios and a crosswalk of the CCRs to cost report cost centers. The quality control code and sample manual validation will highlight any billing anomalies that need to be accommodated by adjusting the costing algorithm.
When an investigator submits a request for data by providing patient identification numbers and the ranges of dates of service, our algorithm first checks for both centers’ institutional review board approval for the study and the appropriate Minnesota Research Authorization status [19, 20] for every patient. It then extracts all available service line data for the specified date ranges and patients from the enterprise data warehouse and REP database and applies the costing algorithm to create inflation- adjusted standardized costs. Investigators always receive services and standardized costs based on the most up-to-date source data, since we store no versions of data sets with cost.
The final data set provided to investigators includes a list of services with inflation-adjusted standardized costs and cost methods for each service, identifiable by HCPCS (or CPT-4) code or UB revenue code, or both; charge master code; patient identifier; date of service; and place of service. We include service description and service line level (vs claim or encounter level) diagnoses. Data for each hospitalization and billing episode are available in a separate file so the investigator has easy access to such information as patient demographic characteristics, admission source, and discharge disposition. To maintain business sensitivity of the data, only the standardized costs are provided.
To better understand the costing process, we present the distribution of cost method by lines of data for Mayo Clinic from 2003 through 2014 (Table 4). Three numbers stand out. The first is the low level—less than 1%—of professional service lines that were not matched to fee schedules and were imputed. The two other interesting categories are those with zero charges. A sample of Mayo Clinic’s zero-charge services provided in the clinic showed that they were primarily unlisted procedures (CPT-4 codes often ending in “99”) that carry no set fee and are reimbursed only on appeal to the CMS carrier; bundled visits such as surgery follow-up and obstetric care that are part of a global payment; and reporting and measurement codes. A sample of hospital zero-charge services showed that 99.7% were “pharmacy labor” lines where the DSS contains separate lines for pharmaceutical preparation labor and the drug itself for cost accounting purposes, but the labor portion has no associated charge. This latter case may not be common among providers, but again, it is shared as another example of how the underlying source data must be understood.
Healthcare cost data used for research break into several broad categories. Some researchers share actual internal costs, but the costing method and degree of health service coverage vary. Intermountain Healthcare investigators have published studies using data from an activity- based cost accounting system, but it only contains hospital costs [21, 22]. Filice et al.  used internal costs from a Department of Veterans Affairs cost accounting system, but the department does not share the confidentiality concerns of nongovernment providers. Abbott and Meara  used actual, fully loaded (ie, incorporates fixed costs, administrative overhead, and more) facility costs but approximated actual professional costs by using physician specialty–specific CCRs multiplied by professional charges. Abbott and Meara  and Chang et al.  state that they used costs derived from institutional financial reports; the types of costs are enumerated, but the cost method is not completely clear. An advantage of using internal costs is that they are often created and validated in accounting systems—although many providers prohibit investigators from disclosing costs considered to be business-sensitive.
Time-based versions of internal costs have been used by several researchers [26,27,28]. Often, the actual costs of supplies and drugs are included, as well as estimates of space, administrative overhead, and equipment depreciation. Sometimes, data are supplemented with estimates and costs from secondary sources . These time-based costs tend to be study specific, and the extent to which these costs are fully loaded is often unclear.
A third category of costs uses a combination of actual costs, Medicare reimbursement, or reimbursement tied to Medicare weights. Schousboe et al. [30, 31] have recommended a combination of Medicare professional and CMS Hospital Outpatient Prospective Payment System reimbursement plus hospital inpatient costs based on diagnosis-related group (DRG) weights. Ritzwoller et al.  seemed to modify the DRG facility costs by adjusting for certain professional services. However, the use of any type of DRG-based inpatient cost prohibits measurement of the cost impact of changes in specific inpatient service utilization or length of stay that would be possible with microcosting. Mabry et al.  added physician and nurse anesthetist costs and charges and removed those of particular services in which the investigators were not interested, modifying Medicare cost report data to create new CCRs to multiply by the charges of several institutions. This methodology would provide a more consistent approach to professional and hospital standardized costs than we have presented, but it would be difficult to implement beyond a study-specific scale. Bittl et al.  used a combination of actual nurse salaries and supply costs plus Medicare fees for physician reimbursement. They did not include facility costs because their study’s patients were not hospitalized.
Our costing algorithm is based on well-understood and widely accepted methodologies . The cost data warehouse has all of the strengths of administrative data for estimating healthcare costs listed by Riley . It avoids three of Riley’s listed limitations: Our patient identifiers do not change over time, we do not have difficulty using data from our accounting systems, and the raw data already are, or can easily be, grouped into visits. Our cost data warehouse was created and is maintained by expert staff familiar with the billing and DSSs, as well as Medicare reimbursement rules, similar to the recommendations of Meenan et al. . The staff has excellent connections to the institutions’ finance colleagues when questions arise. This expertise is particularly important when dealing with CCRs, which, as Riley pointed out, can be complex and difficult to use. As a result, investigators who lack this degree of knowledge can still conduct cost studies. Our identified data can be linked to patient health records and patient registries, and because the data cover both institutions, patient-level utilization and costs can be tracked longitudinally. The data are not limited to patients of a certain age or insurance coverage. Inclusion of professional costs allows the analysis of outpatient care provided in a clinic setting; inclusion of service level costs for the hospitals allows analysis of how utilization can drive cost. The individual service and procedure costs can be aggregated into clinically meaningful categories with tools such as Berenson-Eggers Type of Service  and the Healthcare Cost and Utilization Project’s Clinical Classifications Software for Services and Procedures . The design of the data warehouse allows for easy updates, does not require huge storage space, can be modified as data sources change, and can be expanded to include other providers.
The first publication using our cost data warehouse was in 1999 . The warehouse structure and algorithm have since been updated. Recent publications using this data warehouse cover a wide range of procedures, conditions, and patient care cycles [39,40,41,42,43,44]. These studies’ results are often of interest to other providers, academic researchers, and policy makers.
There are some limitations to using our cost data warehouse. It can be used only to approximate direct healthcare costs. It contains some services (eg, dental, optical) where the cost of care for most patients is incomplete because they receive the services outside of Mayo Clinic and OMC. However, investigators are free to exclude these limited services from their analyses. Services that are not billed, such as follow-up phone calls, but might be available in an activity-based costing system are not included.
Outpatient drugs obtained from a retail pharmacy that might appear in claims data are also not included. Currently, no facility services for long-term care or skilled nursing care or any home health agency services are captured in the data warehouse. Studies may not be able to incorporate the cost of all healthcare provided to patients, especially referral patients. Finally, due to billing rules and the reliance on CMS fee schedules and cost reports, this costing methodology is only applicable for United States providers.
Perhaps the greatest limitation is one common to nearly all sources of standardized costs: the inability to easily examine cost trends. Both professional and hospital standardized costs can vary over time because of factors unrelated to inflation, such as Medicare RVU and conversion factor adjustments, changes in Medicare cost report structure, and changes in how costs and charges are assigned by the institutions to cost report cost centers. Figure 3 illustrates four CPT-4 codes for which the PFS national fees have dramatically changed over 5 years. These variations can make it difficult to discern whether changes in total costs over time are due to changes in utilization or changes in unit costs. However, our costing algorithm can be applied in a limited manner to map all costs to those in effect during a study’s final year, thereby eliminating this issue .
After its development, a provider-based, standardized healthcare cost data warehouse can be maintained easily. It also can be expanded to include other providers, increasing the size of the potential study population and facilitating more powerful, detailed, bottom-up cost studies. We believe that our standardized costs are useful both for providing reasonable and understandable total cost estimates and for describing relative costs. The data warehouse automates the process of generating standardized costs, and therefore, individual investigators, who may not have sufficient knowledge about administrative data, do not have to try to create their own standardized costs on a project-by-project basis.
Cost to charge ratio
Centers for Medicare and Medicaid Services
Current Procedural Terminology Fourth Edition
Decision support system
Gross domestic product
Healthcare Common Procedure Coding System
Olmsted County Healthcare Expenditure and Utilization Database
Physician Fee Schedule
Rochester Epidemiology Project
Relative value unit
Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood). 2008;27(3):759–69.
Riley GF. Administrative and claims records as sources of health care cost data. Med Care. 2009;47(7 Suppl 1):S51–5.
Guglielmo WJ. FTC to doctors: price fixing won’t fly. Med Econ. 2003;80:85.
Kauk J, Hill AD, Althausen PL. Healthcare fundamentals. J Orthop Trauma. 2014;28(7 Suppl):S25–41.
Lipscomb J, Yabroff KR, Brown ML, Lawrence W, Barnett PG. Health care costing: data, methods, current applications. Med Care. 2009;47(7 Suppl 1):S1–6.
Hilsenrath P, Eakin C, Fischer K. Price-transparency and cost accounting: challenges for health care organizations in the consumer- driven era. Inquiry. 2015;10:52.
Xu X, Grossetta Nardini HK, Ruger JP. Micro-costing studies in the health and medical literature: protocol for a systematic review. Syst Rev. 2014;3:47.
Lipscomb J, Ancukiewicz M, Parmigiani G, Hasselblad V, Samsa G, Matchar DB. Predicting the cost of illness: a comparison of alternative models applied to stroke. Med Decis Mak. 1998;18(2 Suppl):S39–56.
Rocca WA, Yawn BP, St Sauver JL, Grossardt BR, Melton LJ 3rd. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc. 2012;87(12):1202–13. Epub 2012 Nov 28
St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ 3rd, Rocca WA. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc. 2012;87(2):151–60.
St Sauver JL, Grossardt BR, Yawn BP, Melton LJ 3rd, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol. 2011;173(9):1059–68. Epub 2011 Mar 23
OPTUM360. RBRVS and relative values [Internet] [2015; cited 21 Aug 2015]. Available from: https://www.optumcoding.com/Category/100037/100197/.
ResDAC. Introduction to medicare cost reports [Internet] [2013 Apr 4; cited 21 Aug 2015]. Available from: http://www.resdac.org/training/media/webinars/introduction-medicare-cost-reports.
Healthcare Cost and Utilization Project. Cost-to-charge ratio files [Internet] [2015b; cited 21 Aug 2015]. Available from: https://www.hcup-us.ahrq.gov/db/state/costtocharge.jsp.
Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995–1996;32(4):476–81.
McDowell B, Hooper A. UHC’s Clinical Data Base (CDB) observed cost methodology. University HealthSystem Consortium [Internet] [2014; cited 21 Aug 2015]. Available from: https://amc.vizientinc.com/docs/7777-21-6817_Observed_Cost_Methodology_2014_Risk_Model.pdf.
US Department of Veterans Affairs. Health Economics Resource Center. Cost-effectiveness analysis [Internet] [2012. Last updated 2015 July 16; cited 21 Aug 2015]. Available from: http://www.herc.research.va.gov/include/page.asp?id=cost-effectiveness-analysis.
Agency for Healthcare Research and Quality (AHRQ). Medical expenditure panel survey: using appropriate price indices for analyses of health care expenditures or income across multiple years [Internet] [2015; cited 21 Aug 2015]. Available from: http://meps.ahrq.gov/mepsweb/about_meps/Price_Index.shtml.
Yawn BP, Yawn RA, Geier GR, Xia Z, Jacobsen SJ. The impact of requiring patient authorization for use of data in medical records research. J Fam Pract. 1998;47(5):361–5.
Jacobsen SJ, Xia Z, Campion ME, et al. Potential effect of authorization bias on medical record research. Mayo Clin Proc. 1999;74(4):330–8.
Curtis JL, Harvey DB, Willie S, et al. Causes and costs for ED visits after pediatric adenotonsillectomy. Otolaryngol Head Neck Surg. 2015;152(4):691–6. Epub 2015 Mar 2
Meier JD, Zhang Y, Greene TH, Curtis JL, Srivastava R. Variation in pediatric outpatient adenotonsillectomy costs in a multihospital network. Laryngoscope. 2015;125(5):1215–20. Epub 2014 Nov 1
Filice GA, Nyman JA, Lexau C, et al. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcusaureus infection. Infect Control Hosp Epidemiol. 2010;31(4):365–73.
Abbott MM, Meara JG. Value-based cleft lip-cleft palate care: a progress report. Plast Reconstr Surg. 2010;126(3):1020–5.
Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17(10):2764–72. Epub 2010 Mar 25
Suh DC, Powers CA, Barone JA, Shin H, Kwon J, Goodin S. Full costs of dispensing and administering fluorouracil chemotherapy for outpatients: a microcosting study. Res Social Adm Pharm. 2010;6(3):246–56.
Nyman JA, Lees CH, Bockstedt LA, et al. Cost of screening intensive care unit patients for methicillin-resistant Staphylococcus aureus in hospitals. Am J Infect Control. 2011 Feb;39(1):27–34.
Shrestha RK, Gardner L, Marks G, et al. Estimating the cost of increasing retention in care for HIV-infected patients: results of the CDC/HRSA retention in care trial. J Acquir Immune Defic Syndr. 2015;68(3):345–50.
Delgado RI, Swint JM, Lairson DR, Johnson NP, Gould KL, Sdringola S. Cost analysis of PET and comprehensive lifestyle modification for the reversal of atherosclerosis. J Nucl Med. 2014;55(1):80–7. Epub 2013 Dec 12
Schousboe JT, Paudel ML, Taylor BC, et al. Estimating true resource costs of outpatient care for Medicare beneficiaries: standardized costs versus Medicare payments and charges. Health Serv Res. 2015; [Epub ahead of print]
Schousboe JT, Paudel ML, Taylor BC, et al. Estimation of standardized hospital costs from Medicare claims that reflect resource requirements for care: impact for cohort studies linked to Medicare claims. Health Serv Res. 2014;49(3):929–49. Epub 2014 Jan 24
Ritzwoller DP, Goodman MJ, Maciosek MV, et al. Creating standard cost measures across integrated health care delivery systems. J Natl Cancer Inst Monogr. 2005;35:80–7.
Mabry CD, Kalkwarf KJ, Betzold RD, et al. Determining the hospital trauma financial impact in a statewide trauma system. J Am Coll Surg. 2015;220(4):446–58. Epub 2015 Jan 9
Bittl JA, Cohen DJ, Seek MM, Feldman RL. Economic analysis of angiography and preemptive angioplasty to prevent hemodialysis- access thrombosis. Catheter Cardiovasc Interv. 2010;75(1):14–21.
Meenan RT, Goodman MJ, Fishman PA, Hornbrook MC, O’Keeffe-Rosetti MC, Bachman DJ. Issues in pooling administrative data for economic evaluation. Am J Manag Care. 2002;8(1):45–53.
Centers for Medicare and Medicaid Services. Berenson-Eggers Types of Service (BETOS) [Internet] [2015; cited 21 Aug 2015]. Available from: https://github.com/chse-ohsu/PublicUseData/tree/master/BETOS.
Healthcare Cost and Utilization Project. Clinical classifications software for services and procedures [Internet] [2015a; cited 21 Aug 2015]. Available from: https://www.hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccssvcproc.jsp.
Wagner JL, Alberts SR, Sloan JA, et al. Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst. 1999;91(10):847–53. Erratum in: J Natl Cancer Inst. 2000;92(2):164–5
Dunlay SM, Shah ND, Shi Q, et al. Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes. 2011;4(1):68–75. Epub 2010 Dec 7
Cook D, Thompson JE, Habermann EB, et al. From ‘solution shop’ model to ‘focused factory’ in hospital surgery: increasing care value and predictability. Health Aff (Millwood). 2014;33(5):746–55.
Kremers HM, Visscher SL, Kremers WK, Naessens JM, Lewallen DG. The effect of obesity on direct medical costs in total knee arthroplasty. J Bone Joint Surg Am. 2014;96(9):718–24.
Maradit Kremers H, Visscher SL, Kremers WK, Naessens JM, Lewallen DG. Obesity increases length of stay and direct medical costs in total hip arthroplasty. Clin Orthop Relat Res. 2014;472(4):1232–9. Epub 2013 Oct 8
Warner DO, Borah BJ, Moriarty J, Schroeder DR, Shi Y, Shah ND. Smoking status and healthcare costs in the perioperative period: a population-based study. JAMA Surg. 2014;149(3):259–66.
Cohoon KP, Leibson CL, Ransom JE, et al. Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. Surgery. 2015;157(3):423–31. Epub 2015 Jan 26
Suri RM, Thompson JE, Burkhart HM, et al. Improving affordability through innovation in the surgical treatment of mitral valve disease. Mayo Clin Proc. 2013;88(10):1075–84.
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Drs. Visscher’s and Borah’s efforts were funded by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery.
Availability of data and materials
Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. Standardized costs described in the paper are created only upon request for specific research cohorts for studies approved by the Institutional Review Boards and the REP Cost and Utilization Study Approval Committee.
SLV led the creation of the CDW, wrote the first manuscript draft, and managed the team edits. JMN and BPY provided substantial edits in the background, discussion, and conclusion portions of the manuscript. MSR and SSA wrote the SAS code to create the CDW and edited the technical portions of the manuscript. BJB was the consultant on the project and comprehensively edited all portions of the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
No individual patient’s data is cited.
Ethics approval and consent to participate
The cost data warehouse contains data for only those patients who have consented under Minnesota Research Authorization to allow their data to be used for research. The cost data warehouse was approved by the Mayo Clinic Institutional Review Board (1593-03) and falls under the Olmsted Medical Center Institutional Review Board approval for the Rochester Epidemiology Project (015-REP-OMC-00). Standardized costs are only provided for identified patient cohorts to investigators who have received approval for their specific research protocols by the Institutional Review Boards of both institutions as well as the Rochester Epidemiology Project Cost and Utilization Study Approval Committee.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
- Cost data warehouse
- Standardized healthcare costs
- Olmsted County Healthcare Expenditure and Utilization Database (OCHEUD)
- Rochester Epidemiology Project (REP)